PERCHERON THERAPEUTICS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.089 AUD | +9.88% |
|
+23.61% | +50.85% |
| 01:44am | Percheron Therapeutics Names Chief Medical Advisor | MT |
| May. 29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
Evolution of the average Target Price on Percheron Therapeutics Limited
Price target over the last 5 years
History of analyst recommendation changes
86.wbLtiLPWar4eqHHna-UAR-EoTMQp2ceF3fs7N-S6nVM.9tbcwP-6R8p3_0aiWKBiNqZgG51hkrPwk7lUTar7yD-45bTr5J497EnfEg~47d07fd1109732d8979455dddd580639
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.089
AUD
Average target price
0.25
AUD
Spread / Average Target
+180.90%
High Price Target
0.27
AUD
Spread / Highest target
+203.37%
Low Price Target
0.23
AUD
Spread / Lowest Target
+158.43%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- PER Stock
- Consensus Percheron Therapeutics Limited
